Magnetic resonance imaging retinal oximetry: A quantitative physiological biomarker for early diabetic retinopathy?

Diabetic Medicine

Volumn 29, Issue 4, 2012, Pages 501-505

  Yang, Y ^a   Zhu, X R ^a   Xu, Q G ^a   Metcalfe, H ^a   Wang, Z C ^a   Yang, J K ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Magnetic resonance imaging; Retinal screening; Retinopathy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; FUNDUS PHOTOGRAPHY; GOLD STANDARD; HOMEOSTASIS; HUMAN; MAGNETIC RESONANCE IMAGING RETINAL OXIMETRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIMETRY; OXYGEN BREATHING; OXYGENATION; PHOTOGRAPHY; PREDICTIVE VALUE; QUANTITATIVE DIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETINA; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EARLY DIAGNOSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MASS SCREENING; MIDDLE AGED; OXIMETRY; OXYGEN; PARTIAL PRESSURE; PREDICTIVE VALUE OF TESTS; RETINA;

EID: 84863246275     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03440.x     Document Type: Article

References (23)

1. Gardiner TA, Archer DB, Curtis TM, Stitt AW. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Microcirculation 2007; 14: 25-38.
2. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD et al. Diabetic retinopathy. Diabetes Care 2003; 26: S99-S102.
3. Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol 2003; 136: 122-135.
4. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K. Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes 2009; 10: S195-S203.
5. Berkowitz BA, Wilson CA. Quantitative mapping of ocular oxygenation using magnetic resonance imaging. Magn Reson Med 1995; 33: 579-581.
6. 2 predicts therapeutic efficacy in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2001; 42: 2964-2969.
7. 2 mapping. Invest Ophthalmol Vis Sci 1996; 37: 2089-2098.
8. Trick GL, Edwards P, Desai U, Berkowitz BA. Early supernormal retinal oxygenation response in patients with diabetes. Invest Ophthalmol Vis Sci 2006; 47: 1612-1619.
9. Satterfield D, Lyons A. Development of a consensus publication by the Centers for Disease Control (CDC): the prevention and treatment of complications of diabetes-a guide for primary care practitioners. Diabetes Educ 1992; 18: 473, 475.
10. Berkowitz BA, Kowluru RA, Frank RN, Kern TS, Hohman TC, Prakash M. Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci 1999; 40: 2100-2105.
11. Xu QG, Chen QH, Xian JF, Wang ZC. Detection of 100% oxygen induced changes in retina using magnetic resonance imaging: a human study. Chin Med J (Engl) 2010; 123: 3277-3281.
12. Wassle H, Boycott BB. Functional architecture of the mammalian retina. Physiol Rev 1991; 71: 447-480.
13. Cheng H, Nair G, Walker TA, Kim MK, Pardue MT, Thule PM et al. Structural and functional MRI reveals multiple retinal layers. Proc Natl Acad Sci U S A 2006; 103: 17525-17530.
14. Harris A, Kagemann L, Cioffi GA. Assessment of human ocular hemodynamics. Surv Ophthalmol 1998; 42: 509-533.
15. Li Y, Cheng H, Duong TQ. Blood-flow magnetic resonance imaging of the retina. Neuroimage 2008; 39: 1744-1751.
16. Duong TQ, Ngan SC, Ugurbil K, Kim SG. Functional magnetic resonance imaging of the retina. Invest Ophthalmol Vis Sci 2002; 43: 1176-1181.
17. Rassam SM, Patel V, Chen HC, Kohner EM. Regional retinal blood flow and vascular autoregulation. Eye (Lond) 1996; 10: 331-337.
18. Trick GL, Edwards PA, Desai U, Morton PE, Latif Z, Berkowitz BA. MRI retinovascular studies in humans: research in patients with diabetes. NMR Biomed 2008; 21: 1003-1012.
19. Burgansky-Eliash Z, Nelson DA, Bar-Tal OP, Lowenstein A, Grinvald A, Barak A. Reduced retinal blood flow velocity in diabetic retinopathy. Retina 2010; 30: 765-773.
20. Pemp B, Polska E, Garhofer G, Bayerle-Eder M, Kautzky-Willer A, Schmetterer L. Retinal blood flow in type 1 diabetic patients with no or mild diabetic retinopathy during euglycemic clamp. Diabetes Care 2010; 33: 2038-2042.
21. Silva KC, Rosales MA, Biswas SK, Lopes de Faria JB, Lopes de Faria JM. Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 2009; 58: 1382-1390.
22. Carrasco E, Hernandez C, Miralles A, Huguet P, Farres J, Simo R. Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 2007; 30: 2902-2908.
23. Jean-Louis S, Lovasik JV, Kergoat H. Systemic hyperoxia and retinal vasomotor responses. Invest Ophthalmol Vis Sci 2005; 46: 1714-1720.